Inhibrx Biosciences Inc. (INBX)
NASDAQ·Healthcare·Biotechnology
$110.97
-0.40%
Mkt Cap $1.78B
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$325.00
Range $325.00 – $325.00
Implied Upside
+192.9%
Consensus $325.00 vs current $110.97